Difference between revisions of "The Future of R&D in Pharmaceutical Industry in 2025"
Peter Friedl (talk | contribs) |
Murat.akguc (talk | contribs) |
||
Line 29: | Line 29: | ||
• [[Effect of development of health care system in emerging market countries to existing pharmaceutical industry]]<br> | • [[Effect of development of health care system in emerging market countries to existing pharmaceutical industry]]<br> | ||
• [[Unification of regulatory approval]]<br> | • [[Unification of regulatory approval]]<br> | ||
• [[Competitiveness through innovation in biotechnology]]<br> | • [[Increasing Competitiveness through innovation in biotechnology]]<br> | ||
• [[ | • [[Changing business models for pharmaceutical industry]]<br> | ||
<br><br>''two more will be added''<br><br> | <br><br>''two more will be added''<br><br> | ||
==Resources== | ==Resources== | ||
* [1] [http://www.nowandnext.com/?action=top_trend/list_trends§orId=10 Top Trends in Healthcare, Medicine and Pharmaceuticals] - What's Next | * [1] [http://www.nowandnext.com/?action=top_trend/list_trends§orId=10 Top Trends in Healthcare, Medicine and Pharmaceuticals] - What's Next | ||
* [2] [http://www.jimcarroll.com/weblog/archives/000757.html 10 Major Healthcare / Pharmaceutical Trends] -Jim Carroll's Blog | * [2] [http://www.jimcarroll.com/weblog/archives/000757.html 10 Major Healthcare / Pharmaceutical Trends] -Jim Carroll's Blog |
Revision as of 23:47, 17 September 2009
EMBA09 team:
Murat Akguc
Ruth Donners
Peter Friedl
Susan Liu
Eva Stjernschantz
Work under construction. In case you have any questions, additions or comments, please do not edit these pages, but you are more than welcome to contact us.
Scenarios.
To be added
Driving forces.
Edited existing ones
• Increasing potential to grow based on new available technology
• Struggling old world economy
• Increasing Empowerment of Consumers in Healthcare System
• Continuously growing demand for new medical applications
• The increasing gap between developed, emerging and poor economies
• The increasing globalization of markets
• Power of the United Nations
• Legal Restrictions for Biotech increasing in certain countries, decreasing in others
two more will be added
Added new ones
• IP rights
• Logistics/Distribution
• Illnesses of global importance/Pandemics
• Research budget in pharmaceutical industry
• Effect of development of health care system in emerging market countries to existing pharmaceutical industry
• Unification of regulatory approval
• Increasing Competitiveness through innovation in biotechnology
• Changing business models for pharmaceutical industry
two more will be added
Resources
- [1] Top Trends in Healthcare, Medicine and Pharmaceuticals - What's Next
- [2] 10 Major Healthcare / Pharmaceutical Trends -Jim Carroll's Blog